Pie Medical Imaging’s CAAS Qardia 2.0 Echocardiography Software Platform is Launched Globally

January 13, 2023—Pie Medical Imaging (PMI), a global cardiac imaging company based in the Netherlands, announced the launch of CAAS Qardia 2.0, a new version of the company’s echocardiography software platform.

CAAS Qardia, which has FDA clearance and CE Mark approval, is available in a server-based or classical stand-alone setup.

According to PMI, CAAS Qardia leverages artificial intelligence–driven workflows for performing key clinical measurements. The platform’s capabilities include myocardial strain analysis of left and right ventricles, stress echo, diastology, and PISA (proximal isovelocity surface area) valve analysis.

The company stated that the platform offers the following:

• Provides a complete and flexible off-cart echocardiography analysis with ease of access
• Automatically creates a report containing all clinically relevant parameters that can be shared with colleagues
• Counteracts foreshortening of the heart’s views that can negatively affect functional measurements including myocardial strain by providing quality control indices; such functionality may give feedback on the appropriateness of the data
• Is a “zero-footprint” solution for in-hospital deployment that allows access from any PC within a hospital network via the web browser
• Vendor neutrality allows health care institutions to use CAAS Qardia for all multivendor echocardiography image sets